SCHEMBL28903752

SCHEMBL28903752

Cn1cc(-c2cc(Cl)n(COCC[Si](C)(C)C)n2)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 2/20 0.36
KDR P35968 1/20 0.36
MET P08581 6/20 0.33
FYN P06241 2/20 0.33
CSF1R P07333 2/20 0.33
DGAT1 O75907 2/20 0.33
TEK Q02763 1/20 0.33
HDAC1 Q13547 1/20 0.33
KDM5B Q9UGL1 1/20 0.32
FGFR1 P11362 1/20 0.32
FGFR2 P21802 1/20 0.32
CLK1 P49759 1/20 0.32
CLK2 P49760 1/20 0.32
DYRK1A Q13627 1/20 0.32
HIPK1 Q86Z02 1/20 0.32
DYRK2 Q92630 1/20 0.32
HIPK2 Q9H2X6 1/20 0.32
HIPK3 Q9H422 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
DYRK1B Q9Y463 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19951691 0.77 MELK (0.39) DGAT1
SCHEMBL2129540 0.76 DGAT1 (0.37) FGFR3KDRFYNDGAT1KDM5B
SCHEMBL29285150 0.75 DGAT1 (0.38) FGFR3KDRDGAT1TEKCLK1
SCHEMBL30070423 0.74 CREBBP (0.33) DGAT1PIM1
SCHEMBL19950254 0.74 CREBBP (0.33) DGAT1PIM1
SCHEMBL29008870 0.74 GPR84 (0.33) METFYNCLK1CLK2DYRK1A
SCHEMBL20489156 0.73 DGAT1 (0.34) DGAT1
SCHEMBL28903845 0.72 MAP4K1 (0.31) DGAT1
SCHEMBL23210897 0.72 AXL (0.35) FGFR3KDRDGAT1
SCHEMBL29907138 0.72 AXL (0.35) FGFR3KDRDGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115819417-A Pyrazolopyridine derivatives as HPK1 modulators and their use for the treatment of cancer 因赛特公司 2023-03-21 CN disclosed
CN-109923114-B Pyrazolopyridine derivatives as HPK1 modulators and their use for the treatment of cancer 因赛特公司 2022-11-01 CN disclosed